Jeff Yass’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.7K Buy
+6,921
New +$28.6K ﹤0.01% 13091
2023
Q1
– Sell
-1
Closed -$28.5K – 12574
2022
Q4
$28.5K Buy
+1
New +$86.6K ﹤0.01% 11639

Other funds holding BJDX

Jeff Yass's BJDX Position: Q3 2026 in Review

Jeff Yass opened a new position in Bluejay Diagnostics (BJDX) in Q3 2026: 6,921 shares worth $23.7K. The stake represents ﹤0.01% of the portfolio and ranks #13091 among its holdings. This is a return to the name: Jeff Yass previously reported a position in BJDX as recently as Q4 2022.

Jeff Yass first reported a position in BJDX in Q4 2022 and has held it in 2 quarters since. The position peaked at $28.5K in Q4 2022. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.

  • Jeff Yass held 6,921 shares of Bluejay Diagnostics worth $23.7K as of Q3 2026.
  • Bluejay Diagnostics was a new Jeff Yass position in Q3 2026.
  • Bluejay Diagnostics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13091 holding.
  • Jeff Yass first reported a position in Bluejay Diagnostics in Q4 2022 and has held it in 2 quarters since.
  • Jeff Yass's Bluejay Diagnostics position peaked at $28.5K in Q4 2022.
  • 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.